Ken Washenik, M.D., Ph.D. is the Medical Director of Bosley and the Chief Executive Officer of the Aderans Research Institute, a biotechnology firm involved in researching tissue engineered hair follicle neogenesis and cellular based hair restoration.
The former director of the Dermatopharmacology Unit at the New York University School of Medicine, Dr. Washenik continues to serve as a clinical investigator and faculty member in the Department of Dermatology.
Dr. Washenik, a well known national and international lecturer, has presented many seminars on dermatopharmacology and dermatology-related issues. His Ph.D. is in Cell Biology and focused on hormone metabolism. He frequently lectures on the effects of hormones on the skin including their effects on hair loss and growth.
Dr. Washenik is the immediate past President of the North American Hair Research Society (NAHRS) and on the Board of Trustees of the Hair Foundation. He is a Director of the Cicatricial Alopecia Research Foundation and a member of the American Academy of Dermatology and the medical honor society, Alpha Omega Alpha. He is a Diplomate of the American Board of Dermatology and a member of the Dermatological Society of Greater New York and the Los Angeles Metropolitan Dermatological Society. He is also on the Board of Governors of the International Society of Hair Restoration Surgery (ISHRS).
Dr. Washenik has published numerous scientific and medical articles in peer review journals including Endocrinology, Journal of the American Academy of Dermatology, Archives of Dermatology, The Lancet and The New England Journal of Medicine.
Dermatology is recognized as a burgeoning area with exciting innovation for patients, doctors, and investors.
Pascale Communications was on the scene at the annual American Academy of Dermatology (AAD).
DENVER — R. Rox Anderson, MD, professor of dermatology at Harvard Medical School and director of the Wellman Center for …